Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
7 hedge funds and large institutions have $433K invested in Meihua International Medical Technologies in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
347% more capital invested
Capital invested by funds: $96.8K → $433K (+$336K)
75% more funds holding
Funds holding: 4 → 7 (+3)
0.99% more ownership
Funds ownership: 0.23% → 1.22% (+0.99%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$271K |
| 2 |
Renaissance Technologies
New York
|
+$130K |
| 3 |
VF
Virtu Financial
New York
|
+$26.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.34K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$184 |
Top Sellers
MHUA Hedge Fund Activity: Q4 2023 in Review
7 of the 6,870 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q4 2023, worth a combined $433K — up 347% from $96.8K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MHUA positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $271K.
- 7 institutional investors held Meihua International Medical Technologies (MHUA) as of Q4 2023, up from 4 in Q3 2023.
- Funds reported $433K of Meihua International Medical Technologies stock for Q4 2023, up 347% quarter-over-quarter.
- 3 funds opened new Meihua International Medical Technologies positions in Q4 2023 and 0 closed out, a net change of +3 holders.
- The largest Meihua International Medical Technologies buyer in Q4 2023 was Marshall Wace, an estimated $271K added.
Based on aggregated 13F filings for Q4 2023.